ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,567.19
1.06%
US Tech 100
19,828.00
0.95%
Dow Jones
39,375.87
0.17%
Brent Oil
86.775
0.00%
Bitcoin
56,606.40
-0.08%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Inhibrx Biosciences Inc (INBX)

  7. Inhibrx Biosciences Inc (INBX) News

INBX

Inhibrx Biosciences (INBX)

Inhibrx Biosciences Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:INBX
DateTimeSourceHeadlineSymbolCompany
02/28/20249:15AMPR Newswire (US)Inhibrx Reports Fourth Quarter and Fiscal Year 2023 Financial ResultsNASDAQ:INBXInhibrx Biosciences Inc
02/28/20249:12AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
02/28/20249:10AMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:INBXInhibrx Biosciences Inc
02/14/20244:12PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:INBXInhibrx Biosciences Inc
02/06/20244:30PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
01/26/202412:12PMPR Newswire (US)Kuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to Contact Law FirmNASDAQ:INBXInhibrx Biosciences Inc
01/23/20245:25PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
01/23/20246:38AMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:INBXInhibrx Biosciences Inc
01/23/20246:35AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
01/23/20246:05AMDow Jones NewsSanofi to Buy Assets From Inhibrx in Deal Valued at Up to $2.2 Billion -- UpdateNASDAQ:INBXInhibrx Biosciences Inc
01/23/20245:40AMIH Market NewsWall Street Highlights: Vroom Shuts Down Online Car Sales, Ericsson Warns of Decline Outside China, and MoreNASDAQ:INBXInhibrx Biosciences Inc
01/23/20241:00AMPR Newswire (US)Inhibrx Announces Sale of INBRX-101 to Sanofi for an aggregate value of up to $2.2BNASDAQ:INBXInhibrx Biosciences Inc
11/09/20234:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
11/09/20234:01PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBXInhibrx Biosciences Inc
11/09/20234:00PMPR Newswire (US)Inhibrx Reports Third Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Biosciences Inc
11/02/20239:16AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
11/02/20239:15AMPR Newswire (US)Inhibrx Announces Preliminary Data from the Phase 1 Trial of INBRX-109 for the Treatment of Ewing SarcomaNASDAQ:INBXInhibrx Biosciences Inc
10/18/20234:00PMPR Newswire (US)Inhibrx Announces Participation in Upcoming Scientific ConferencesNASDAQ:INBXInhibrx Biosciences Inc
09/19/20234:03PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
09/19/20234:00PMPR Newswire (US)Inhibrx Retains Rights to INBRX-101 for the Treatment of Alpha-1 Antitrypsin Deficiency Outside of the United States and CanadaNASDAQ:INBXInhibrx Biosciences Inc
08/31/20234:06PMEdgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:INBXInhibrx Biosciences Inc
08/29/20239:03AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:INBXInhibrx Biosciences Inc
08/29/20239:00AMPR Newswire (US)Inhibrx Announces $200 Million Private Placement FinancingNASDAQ:INBXInhibrx Biosciences Inc
08/07/20234:03PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:INBXInhibrx Biosciences Inc
08/07/20234:00PMPR Newswire (US)Inhibrx Reports Second Quarter 2023 Financial Results and Recent Corporate HighlightsNASDAQ:INBXInhibrx Biosciences Inc
05/30/20234:11PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INBXInhibrx Biosciences Inc
05/30/20234:08PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INBXInhibrx Biosciences Inc
05/30/20239:46AMDow Jones NewsInhibrx Granted FDA Fast Track Designation for INBRX-101NASDAQ:INBXInhibrx Biosciences Inc
05/30/20239:04AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INBXInhibrx Biosciences Inc
05/30/20239:00AMPR Newswire (US)Inhibrx Granted Fast Track Designation for INBRX-101 for the Treatment of Alpha-1 Antitrypsin DeficiencyNASDAQ:INBXInhibrx Biosciences Inc
 Showing the most relevant articles for your search:NASDAQ:INBX

Your Recent History

USOTC
RSPI
RespireRx Pharmaceuticals (PK)
USOTC
SPZI
Spooz (PK)
USOTC
IGPK
Intergrated Cannabis Sol... (PK)
NASDAQ
NVDA
NVIDIA
NASDAQ
TSLA
Tesla
AMEX
SPY
SPDR S&P 500
USOTC
PSRU
Valiant Eagle (PK)
USOTC
ENZC
Enzolytics (PK)
USOTC
SFRX
Seafarer Exploration (PK)
USOTC
BLEG
Branded Legacy (PK)
USOTC
AXXA
Exxe (PK)
USOTC
GTVH
Golden Triangle Ventures (PK)
USOTC
ERHE
ERHC Energy (CE)
COIN
SHIBUSD
SHIBA INU
USOTC
CLNV
Clean Vision (QB)
USOTC
NSAV
Net Savings Link (PK)
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved